Abstract:Introduction Cellular senescence – defined as a stable cell-cycle arrest combined with stereotyped phenotypic changes – plays a causal role in a variety of aged-associated lung diseases. Previous work by our groups and others has shown that cellular senescence contributes to the pathobiology of both lung emphysema and lung fibrosis. However, it remains a conundrum on how these different pathological entities share a common pathogenic mechanism, i.e. lung senescent cell accumulation. The mTOR (mechanistic target of rapamycin) pathway has been validated as o,ne of a cell-senescence inducer. We reasoned here that activation of mTORC1 could either promote lung emphysema or fibrosis depending on the specific lung cell types undergoing senescence. Methods We generated mice with conditional deletion of the tuberous sclerosis complex heterodimer TSC1 (a negative mTORC1 regulator) in selected lung cells including fibroblast and SMCs (SM22-TSC1–/–mice), endothelial cells (P-ECs; PDGF-TSC1–/–mice), and alveolar epithelial cells (AECs; SPC-TSC1–/–mice) Mice with conditional and cell-specific TSC1 deletion were generated using the cre-lox strategy. Results Compared with controls, SM22-TSC1–/–mice developed lung fibrosis as assessed by the Ashcroft score but without lung emphysema as assessed by the absence of changes in the mean linear intercept. In contrast, PDGF-TSC1–/–mice developed lung emphysema with no significant associated lung fibrosis whereas SPC-TSC1–/–mice developed both lung emphysema and lung fibrosis, although to a lower extent than SM22TSC1 mice. This occurred together with an increase of the lung protein levels of the senescence markers p16 and p21as well as of the DNA damage marker gH 2 AX in the three mice strains, with p16 being higher in SM22-TSC1–/–mice than in the two other mutant mice. By the phenotypes of the mutant mice, the fibrosis markers Col1A, PAI1, and vimentin Col3, were increased in both SM22 and SPC-TSC1–/–mice whereas Col3 and pSmad3 were increased only in SM22-TSC1–/–mice. As expected TSC1 deletion in targeted cells leads to higher lung levels of p-AktSer-473, p-GSK-3, p-S6K, and p–4E-BP1 after 3 months. To question whether mice with TSC1 deletion in selected cells developed lung alterations due to the induction of cell senescence, we treated the three mutant mouse strains with the senolytic compound ABT263 (50 mg/kg/day) 3 times a week during the 3 weeks following tamoxifen treatment. Treatment with ABT263 efficiently reduced the phenotypic alterations in the three mouse strains. Conclusion Lung mTOR activation may lead to either lung fibrosis or emphysema via senescence of selected lung cells.

Conditional expression of transforming growth factor-α in adult mouse lung causes pulmonary fibrosis

TGF-β, Smad3 and the process of progressive fibrosis

Mice Overexpressing Latent Tgf-Beta 1 Are Protected Against Renal Fibrosis In Obstructive Kidney Disease

Mice overexpressing latent TGF-β1 are protected against renal fibrosis in obstructive kidney disease

Inhibition of the αvβ6 integrin leads to limited alteration of TGF-α-induced pulmonary fibrosis

TGF{beta} drives fibrotic remodeling via modulation of homeostatic and pathological fibroblast populations in a murine model of pulmonary fibrosis

Transforming growth factor alpha is a critical mediator of radiation lung injury

TGF2 and TGF3 isoforms drive fibrotic disease pathogenesis

Release of biologically active TGF-β1 by alveolar epithelial cells results in pulmonary fibrosis

Expression of Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Lung Fibrosis of TGF-β1 Transgenic Mice

Transforming Growth Factor Β Suppresses Glutamate–cysteine Ligase Gene Expression and Induces Oxidative Stress in a Lung Fibrosis Model

Expression Change of TGF Β1 in Lungs of Rats′ Bleomycin-indued Pulminany Gibrosis Model

Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype

CD4+CD25+FoxP3+ Regulatory Tregs Inhibit Fibrocyte Recruitment and Fibrosis Via Suppression of FGF-9 Production in the TGF-Î²1 Exposed Murine Lung

Interferon-γand Transforming Growth Factor-Β1-producing T Lymphocytes in Lung Tissue of Mice with Pulmonary Fibrosis

TGF-beta1 Transgenic Mouse Model of Thoracic Irradiation: Modulation of MMP-2 and MMP-9 in the Lung Tissue

Chronic Activation of the Renin-Angiotensin System Induces Lung Fibrosis

TGF-β activation impairs fibroblast ability to support adult lung epithelial progenitor cell organoid formation.

MTOR dependent-induction of lung cell senescence leads to lung fibrosis or emphysema

Conditional overexpression of TGFβ1 promotes pulmonary inflammation, apoptosis and mortality via TGFβR2 in the developing mouse lung

Epithelium-specific Deletion of TGF-β Receptor Type II Protects Mice from Bleomycin-Induced Pulmonary Fibrosis.